ArticleClinical cancer research : an official journal of the American Association for Cancer Research2009

Circulating levels of soluble KIT serve as a biomarker for clinical outcome in gastrointestinal stromal tumor patients receiving sunitinib following imatinib failure.

Samuel E Deprimo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.